Videos

Dr. Edward Garon speaks about how differences in patient populations with lung cancer can make it difficult to interpret and act on data.

ALK Gene Rearrangement and PD-L1 Expression

Dr. Edward Garon does not believe there is much value in utilizing PD-L1 inhibitors for pateints with ALK gene rearrangement.

A Look at PD-1 and PD-L1 Inhibitors

Dr. Edward Garon discusses the use of PD-1 and PD-L1 inhibitors in patients with lung cancer.

Shifts in Lung Cancer Treatment

Dr. Edward Garon reviews how certain drugs can change the landscape for treating patients with lung cancer.

Common Presenting Factors for NSCLC

Dr. Edward Garon provides an overview of the most common presenting clinical features in adults with non-small cell lung cancer (NSCLC).

Who Should be Screened for Lung Cancer?

Dr. Edward Garon identifies the target population for lung cancer screening.

Screening for Lung Cancer

Dr. Edward Garon talks about the best approaches for screening patients for lung cancer.

Smoking Cessation and Lung Cancer

Dr. Edward Garon discusses the importance of smoking cessation programs for patients diagnosed with lung cancer.

Perspectives on Carcinoid Syndrome (CS) Diarrhea

By David C. Metz

Listen to perspectives on CS diarrhea from Dr. David C. Metz, gastroenterologist and neuroendocrine tumor expert.